Company’s first-of-a-kind intelligent imaging system aims to expand patient access, streamline high-quality cardiac care, and establish the foundation for future robotic interventions
LOS GATOS, Calif., Nov. 5, 2026 /PRNewswire/ — Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, today announced it has raised up to $160 million in Series B structured financing. GE HealthCare led the round, with participation from returning investors Unorthodox Ventures, PA MedTech, and AMED. The financing will support the company’s mission to transform the cardiac catheterization laboratory through intelligent imaging technology designed to simplify procedures, increase autonomy, alleviate resource constraints, and unlock the possibilities for future robotic-enabled interventions.









